PFA-100 and flow cytometry: can they challenge aggregometry to assess antiplatelet agents, other than GPIIbIIIa blockers, in coronary angioplasty? - Hézard, N; Metz, D; Nazeyrollas, P (Thromb Res, 2003)
et al.